Sodium-glucose cotransporter-2 inhibitors could be useful for people with ATTR-CM
SGLT2is appeared to be safe for patients with ATTR-CM and may result in fewer hospitalizations and improved kidney function.
News
-
-
Study finds variability in signs of heart failure in patients with ATTR-CM
The study results highlighted the need to broaden diagnostic criteria for transthyretin amyloid cardiomyopathy, or ATTR-CM.
